C. Abasq‐Thomas
Impact in
- Dermatology top 10%
- Dermatology and Skin Diseases
-
- Urticaria and Related Conditions
Papers in
-
- Autoimmune Bullous Skin Diseases 5
-
- Dermatology and Skin Diseases 5
- Co-authors
- L. Misery (20 shared papers)E. Brenaut (9 shared papers)Séverine Audebert‐Bellanger (3 shared papers)S. Ferkal (1 shared paper)P. Wolkenstein (1 shared paper)A. Zagnoli (1 shared paper)Raphaële Le Garrec (1 shared paper)Olivier Gouin (1 shared paper)
In The Last Decade
C. Abasq‐Thomas
16 papers receiving 156 citations
Peers
Comparison fields: 5 of 38
- Dermatology 40
- Rheumatology 38
- Physiology 57
- Neurology 32
- Immunology and Allergy 12
Countries citing papers authored by C. Abasq‐Thomas
This map shows the geographic impact of C. Abasq‐Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Abasq‐Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Abasq‐Thomas more than expected).
Fields of papers citing papers by C. Abasq‐Thomas
This network shows the impact of papers produced by C. Abasq‐Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Abasq‐Thomas. The network helps show where C. Abasq‐Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Abasq‐Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 42 | |
| 2 | 2015 | 26 | |
| 3 | 2021 | 22 | |
| 4 | 2015 | 18 | |
| 5 | 2018 | 13 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 9 | |
| 8 | 2014 | 4 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 3 | |
| 11 | 2021 | 2 | |
| 12 | 2016 | 2 | |
| 13 | 2021 | 2 | |
| 14 | 2019 | 2 | |
| 15 | 2020 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2023 | 0 | |
| 20 | 2024 | 0 |
About C. Abasq‐Thomas
C. Abasq‐Thomas is a scholar working on Pathology and Forensic Medicine, Dermatology, Surgery, Genetics and Urology, having authored 23 papers that have together received 162 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (5 papers), Autoimmune Bullous Skin Diseases (5 papers), Hair Growth and Disorders (3 papers), Vascular Malformations and Hemangiomas (3 papers), Urticaria and Related Conditions (3 papers), Neurofibromatosis and Schwannoma Cases (2 papers), Skin and Cellular Biology Research (2 papers) and Genetic and rare skin diseases. (2 papers). The work is most often cited by research in Dermatology (40 citations), Rheumatology (38 citations), Physiology (57 citations), Neurology (32 citations) and Immunology and Allergy (12 citations). C. Abasq‐Thomas has collaborated with scholars based in France, Canada and Germany. Frequent co-authors include L. Misery, E. Brenaut, Séverine Audebert‐Bellanger, S. Ferkal, P. Wolkenstein, A. Zagnoli, Raphaële Le Garrec, Olivier Gouin, Anne‐Marie Roguedas‐Contios and Cédric Gouédard. Their work appears in journals such as Acta Dermato Venereologica, British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, JAMA Dermatology and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.